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Aim: The aim of this study was to evaluate the frequency of existence of thyroid extratumoral normo- and microfollicular tissue in patients 
with thyroid carcinoma and peculiarities of apoptosis in mentioned tissue. Materials and Methods: Using samples of normo- and micro-
follicular thyroid tissue it was determined the content of fragmented DNA and intensity of stimulated internucleosomal DNA fragmenta-
tion; activities of caspase-3 and cysteine lysosomal cathepsins. Results: It was found that normofollicular tissue is observed more often 
in patients with nodal euthyroid goiter but microfollicular tissue is more common for patients with carcinoma. Extratumoral microfol-
licular tissue was found in the thyroid of patients above 50 years old mostly, and more rarely in young ones. The fragmented DNA con-
centration in microfollicular tissue was lower by a factor of 3.5 and intensity of stimulated internucleosomal DNA fragmentation was also 
decreased. Activity both of cathepsin B in lisosomes and caspase-3 in lysates of such tissue was also decreased. Conclusions: The decrease 
of intensity of spontaneous apoptosis and the absence of its modulation/induction following proapoptotic factors in extratumoral micro-
follicular thyroid tissue may be considered as a respond of the thyroid gland tissue to an existence of carcinoma.
Key Words: thyroid extratumoral microfollicular tissue, internucleosomal DNA fragmentation, caspase-3, lysosomal cathepsins, apoptosis.
A century ago, it was stated by Isaac Levin that tumor 
development and growth depend not only on host’s im-
mune status, but also on local interactions between 
tumor and host [1]. However, we have meanwhile only 
a few information concerning metabolic changes in cells 
of tumor-bearing organs. During last 50–60 years re-
searchers’ attention was mostly focused on the study 
of tumor cell microenvironment that differs from normal 
cell microenvironment without any doubt [2]. 
As an example of cell metabolism damage in any 
organ-bearing tumor may be the data concerning lac-
tate formation in tumor cells due to aerobic glycolysis 
activation that leads to the pH decrease not only in tu-
mor cells, but also in areas being outside of the tumor 
by means of proton “leakage” [3]. Moreover more high 
lactate dehydrogenase activity is registered in extratu-
mor tissue also [4]. Such acid microenvironment is toxic 
for normal cells that leads to their destruction [3] and 
well correlated with metastasis.Very often the availability 
of the tumor is accompanied by various metabolic dis-
turbances even in areas being far from tumor setting [5]. 
An increased quantity of aberrant thyrocytes is de-
scribed for tumor-affected thyroid gland (TG) in the 
all non-affected areas [6]; there are data concerning 
both increased expression of some molecules taking 
part in proliferation and apoptosis regulation [7] and 
increased concentration of fragmented DNA in com-
pare to such in extranodular tissue in patients with 
euthyroid goiter [8]. 
The TG activity is known may be changed in physio-
logical conditions or due to the thyroid pathology; the 
follicular structure of TG tissue may also be changed: 
the gland may have normo-, micro-, macro-, or hetero-
follicular structure. During the study of disturbances 
in mechanisms of apoptosis in patients with benign 
as well as malignant TG neoplasms we have observed 
the existence of extratumoral tissue without histological 
features of pathology in patients with carcinoma that 
had more often microfollicular structure compare to pa-
tients with goiter. The aim of this work was to analyse 
frequency of existence of thyroid extratumoral normo- 
and microfollicular tissue of patients with thyroid car-
cinomas and peculiarities of apoptosis of such tissues.
MATERIALS AND METHODS
Tissue. It have been investigated extratumoral/
extranodular tissues (258 samples) obtained during 
total or hemithyroidectomy to determine frequency 
of existence of thyroid tissue of different follicular 
structures without pathological changes when car-
cinoma or benign node (e.g., euthyroid goiter) are 
present. All patients were informed about investigation 
for scientific purposes. This study has been apptoved 
by Institute’s Committee on Biological & Medical Ethics.
All tissue samples for biochemical investigation 
(90 samples) had no macro- or microscopical fea-
tures of pathological changes. Depending on the type 
of follicular structure all samples were divided into 
three groups — tissue of normofollicular structure 
(42 samples, 1st group), tissue of micro- or micro-
normofollicular structure (30 samples, 2nd group), and 
tissue of macro- or macro-normofollicular structure 
(18 samples, 3rd group). 
Fragmented DNA assay. Concentration of low 
molecular weight DNA fragments was analysed in su-
pernatant fluid following cell lysis during tissue homog-
enization in в 10 mM Na-ЕDTA-Tris-HCl buffer, рН 7.8, 
containing 0.5% Triton Х-100 and centrifugation 
(5.000 rpm, 15 min). The pellet containing high mo-
lecular weight DNA inside chromatin was suspended 
in the initial buffer (but without Triton Х-100). Quan-
titative DNA content in both fractions was stimated 
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by means of a diphenylamine reaction [9] and given 
as 1 μg/1 g of tissue. The part of fragmented DNA was 
calculated as percent to the total amount.
The intensity of stimulated internucleosomal 
DNA fragmentation assay. To determine the intensity 
of stimulated internucleosomal DNA fragmentation, tis-
sue slices (50–100 mg) were previously incubated dur-
ing 4 h at 37 0С in Krebs-Ringer PBS (1 ml, pH 6.0) that 
permited to increase the quantity of cells on the onset 
of terminal step of apoptosis under hypoxia. The next 
steps of DNA isolation and purification were the same 
as discribed earlier [10]. DNA electrophoresis (1 h, 
90 mV) was carried out in 1.7% agarose gel (“Sigma”, 
USA, or “Lachema”, Czech Republic) using 10 mМ Tris-
EDTA buffer, рН 7.0–7.2 containing ethidium bromide 
(1 μg/ml). The markers as large as 100–1000 base pairs 
(bps) that have been used corresponded to DNA frag-
ments. Quantitative analysis of low molecular weight 
DNA fragments (200, 400, 600, and 800 bps) was car-
ried out using the program “Photo Capt Mw”. Relative 
nucleosome contents were calculated from total area 
of all DNA peaks taken as 100%.
Caspase-3 and cysteine lysosomal cathepsin 
activity assay. Obtaining of tissue lysates and deter-
mination of caspase-3 activity (acetyl-Asp-Glu-Val-
Asp-p-nitroanilide being as a substrate) were provided 
using kit for estimation of caspase activity (“CASP-3”, 
Sigma, USA). Activity of cysteine lysosomal cathepsins 
was estimated both in cytosol and lysosomes accor-
ding to [11] using synthetic substrates N2-benzoyl-
DL-arginine-4-nitroanilide (for the cathepsin В) and L-
leucine-4-nitroanilide (for the cathepsin Н) or azocasein 
being previously denatured by 6 M urea solution (for the 
cathepsin L). Activity of caspase-3, cathepsin В, and 
cathepsin Н was given as μmoles of p-nitroaniline that 
are cleaved from the substrate during 1 h of incuba-
tion per 1 mg of protein. Activity of cathepsin L is given 
in conventional units of low molecular weight peptide 
(non-precipitated by trichloracetic acid) following 
1 h of incubation per 1 mg of protein. 
The allocation of lysosomal and cytosol frac-
tions, and protein concentration assay. Lysosomal 
and cytosol fractions were isolated by means of dif-
ferential centrifugation and protein content was esti-
mated according to Lowry modification [12].
Statistical analysis. Data were given as mean ± 
standard error (S.E.) and analyzed statistically using 
a one-tail analysis of the Student’s t-test and χ2-test 
for comparison between groups. Differences were 
considered significant at p < 0.05. 
RESULTS 
Among 258 extranodal TG samples studied, dif-
ferent features of pathological changes (lymphoid 
infiltration, invasion of tumor cells, chronic thyroiditis, 
autoimmune thyroiditis, sclerotic changes of stroma 
tissue, marked hyperplasia, cysts) were detected 
in 168 ones (65,1%). Pathological events in extranodal 
tissue were found mostly in patients with carcinomas 
(131 samples/191; 68.5%) comparing to patients with 
euthyroid goiter (37 samples/67; 55.2% p=0,0483, 
χ2-test). Among the intact tissue samples with normal 
follicular structure were mostly detected in nodular 
euthyroid goiter (Table 1, p= 0.0071, χ2-test) and 
tissue with microfollicular structure has been mainly 
found at carcinomas (p = 0.00003). In such patho-
logical conditions extratumoral/extranodular tissue 
of macrofollicular structure was seen with the same 
frequency (p = 0.576). 
Table 1. Existence of an extratumoral/extranodular tissue of a different 
follicular structure in a TG of patients with carcinoma and a nodular euthy-
roid goiter
Patients 1st group 2nd group 3rd group
patients with carcinoma (n=60) 26 (43.3%) 26 (43.3%) 8 (13.4%)
patients with nodular goiter (n=30) 20 (66.7%)* 3 (10.0%)* 7 (23.3%)
Note: * — significant difference in the 1st and the 2nd group of patients, 
p<0.05, χ2-test; n — number of observations.
Such differences in distributions of normo- and 
microfollicular tissue in TG affected with carcinoma 
do not depend on patients’ sex (p=0.182, χ2-test), 
on tumor metastatic potential (p = 0.281), tumor inva-
sive properties (p = 0.943), or tumor location — tumor-
containing lobe or contralateral one (p=0.111). At the 
same time, it may be clearly detected the dependence 
of existence of tissue of different follicular structure 
on patients’ age (extratumor microfollicular tissue 
is mostly present in TG of patients above 50 years and 
significantly rarer in young patients). On the contrary, 
it was found an opposite situation for distribution 
of normofollicular tissue (Table 2). No dependence has 
been noted in the distribution of extranodal tissue with 
different follicular structures with age of patients hav-
ing euthyroid goiter. The differences in existence of tis-
sue with different follicular structures are statistically 
significant in 30–50 years old patients as well as above 
50 years (р=0.0295 and 0.0183, respectively, χ2-text).
Table 2. Existence of an extratumoral/extranodular tissue of a different  
follicular structure in a TG of different age patients
Age Cancer Goitern 1st group 2nd group n 1st group 2nd group
Under 30 year 18 13 (72.2%) 5 (27.7%) 6 5 (83.3%) 1 (16.6%)
31–50 years 21 12 (57.1%) 9 (42.9%) 14 13 (92.9%) 1 (7.1%)
Up 50 year 13 1 (7.7%)*# 12 (92.3%)*# 3 2 (66.7%) 1 (33.3%)
Note: * — significantly different from group under 30 year; # — from group 
31–50 years,  p<0.05, χ2-test, n — number of observations.
Concentration of fragmented DNA in tissue of mi-
crofollicular structure was by a 3.5 fold lower, its part 
in total DNA content was by a 2.4 fold also lower com-
paring to tissue of normofollicular structure (Table 3). 
It has been found that mononucleosome content 
in samples of DNA from microfollicular tissue has been 
decreased by 55%, total oligonucleosome content (the 
nucleosome size was 200, 400, 600, and 800 bps) has 
been by 23% lower than in samples of DNA isolated 
from normofollicular tissues (Table 4). 
Table 3. Concentration of the DNA in an extratumoral thyroid tissue 
of a different follicular structure
Parameters 1st group (n=6) 2nd group (n=4)
High-molecular DNA (μg/g) 1.00 ± 0.09 0.94 ± 0.01
Low-molecular DNA (μg/g) 0.57 ± 0.07 0.16 ± 0.01*
Part of fragmented DNA (%) 35.81 ± 2.03 14.92 ± 0.51*
Note: * — significantly different from the 1st group, p < 0.05, Student’s t- test; 
n — number of observations.
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Table 4. Level of oligonucleosoms in DNA extracted from an extratumoral 
thyroid tissue of a different follicular structure 
Size of nucleosomes 1st group (n=6) 2nd group (n=4)
200 bp. (%) 8.77 ± 0.64 3.94 ± 0.94*
400 bp. (%) 5.45 ± 0.48  3.49 ± 1.34
600 bp. (%) 8.17 ± 0.41  7.19 ± 1.24
800 bp. (%) 6.63 ± 0.65  6.89 ± 1.12
Total amount (200–800) bps. (%) 29.0 ± 0.39 22.3 ± 2.87*
Note: * — significantly different from the 1st group, p < 0.05, Student’s t- test, 
n — number of observations.
Caspase-3 activity in lysates of microfollicu-
lar tissue was significantly lower than in tissue 
of normofollicular structure (0.038±0.022 versus 
0.156±0.028 μmoles p-nitroaniline/h/mg of protein, 
respectively, p<0.05). Activity both of cathepsins Н and 
L in lysosomal and cytosol fractions isolated from nor-
mo- or microfollicular tissues do not differ significantly 
(data not shown). Cathepsin B activity was drastically 
lower in lysosomal fraction isolated from microfol-
licular tissue (22.45±3.29 versus 11.1±2.89 μmoles 
p-nitroaniline/h/mg of protein, respectively, p<0.05).
DISCUSSION 
While studying both intensity and mechanisms 
of regulation of apoptosis under thyroid pathology 
it was detected the prevalence of extratumor micro-
follicular tissue in presence of carcinoma that was 
confirmed statistically. The extratumor microfollicular 
tissue was seen more often (in a factor of 4.5) than 
extranodular tissue of the similar structure in case 
of euthyroid goiter. As it is known the microfollicular 
structure of TG of healthy persons is characteristic 
for children TG. Following aging, the TG becomes 
more homogenous, follicles of average size are pre-
dominant. However, in healthy grown-up and older 
persons it was observed the microfollicular changes 
of TG architectonics more oft [13]. Such changes are 
thought to be correlated with physiological TG changes 
stipulated by aging. The increase of microfollicular 
TG elements and the decrease of normofollicular ones 
in extratumoral tissue of patients with carcinoma may 
be related to their age. However, such dependence 
is absent in patients with euthyroid goiter. That is why 
the age cannot be the only cause of more oft occur-
rence of microfollicular extratumoral tissue in TG with 
carcinoma. Other factors, such as patients’ sex, tumor 
aggressiveness, location of tumor in TG are not crucial. 
As it is known the decrease of follicle sizes takes 
place due to the factors stimulating the TG func-
tion. It is shown that level of serum thyrotropin (TSH) 
in patients with carcinoma may be increased, being, 
however, not significantly higher than the upper normal 
level [14–16]. Some authors think that such increase 
is observed only in patients with papillary but not with 
follicular carcinomas [15]. Other investigators have 
found the increase of serum TSH concentration in pa-
tients with papillary, follicular, and undifferentiated car-
cinomas [16]. Consequently, despite of the absence 
of clinical symptoms indicating the damage of thyroid 
function in patients with carcinoma level of thyroid hor-
mones remains within normal ranges. It is impossible 
to deny a possibility of definite stimulation TG by the 
TSH (in a case of subclinical hypothyroidism) that 
resulted in the decrease of follicle volume.
In extratumoral TG areas of microfollicular struc-
ture, it was not found any significant changes of lyso-
somal cysteine cathepsins H and L activity under such 
stimulation. Taking into account their role in thyro-
globulin processing ( cathepsin L takes part in all steps, 
but cathepsin H is active during complete protein 
degradation [17]), it may be an indirect evidence that 
there is absent significant quantitative shifts in synthe-
sis of thyroid hormones. At the same time, a drastical 
droping of cathepsin B activity in lysosomes isolated 
from microfollicular tissue may lead to small decrease 
of content of thyroid hormones in blood: cathepsin 
B takes part in this process at steps both of protein 
solubilization and thyroxine formation [17]. It has been 
earlier shown that thyroxine, but not triiodothyronine 
content is something lower in blood of patients with 
carcinoma [16]. Such decrease of circulating thyro-
xine (something lower than normal range) is proposed 
to be as a cause of a little increase of TSH secretion 
and, consequently, diminished follicle volume.
On the other hand, as it was ascertained earlier the 
release of lysosomal proteases into the cytosol due 
to permeability of lysosomal membrane is dominant 
intracellular phenomenon but not as a part of the fol-
lowing later stages of cell death throughout the apop-
tosis. Releasing of proteases including cathepsins 
from lysosomes causes the mitochondrial disfunction 
followed by activation of caspases and cell death [18]. 
In this work, no cathepsin release into the cytosol from 
microfollicular tissue has been registered. This fact 
and our data obtained concerning the transmembrane 
potential as well as intensity of swelling of mitochondria 
isolated from such tissue [19] suggest that there are 
absent activation of apoptosis in thyroid extratumoral 
microfollicular tissue.
However, the spontaneous apoptosis in such tis-
sue may by inhibited. Such assumption is confirmed 
by a drastic drop of caspase-3 (whose participa-
tion in apoptosis has been confirmed of numerous 
researchers [20, 21]), as well as by low cathepsin 
B activity (its role in regulation of apoptosis has been 
already established [18]). The decrease of activity 
of these proteases in microfollicular thyroid tissue 
coincides also with the data concerning decreased 
level of fragmented DNA (Table 3) and gradual delay 
of swelling of mitochondria [19]. All mentioned above 
and significant decline of mitochondrial transmem-
brane potential [19] may be an evidence of the change 
of membrane permeability and decrease of proapoptic 
molecule releasing from mitochondria. 
In addition, some disturbances of mitochondrial 
function in response to apoptosis modulating factors 
in thyroid tissue have been shown earlier. It may be im-
portant for realization of cell death following proapop-
tosis signals. First of all, mitochondria in microfollicular 
tissue becomes to be resistant to the affect of calcium 
ions (pore opening inducers) and antioxidants that 
can modulate this process. Intensity of mitochondria 
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swelling (the most adequate parameter permitting 
to estimate the nonspecific mitochondrial membrane 
permeability) has not been changed following calcium 
ions, melatonin or α-tocopherol addition to the incuba-
tion medium that is inherent for normofollicular tissue. 
The transmembrane potential is an integral parameter 
describing energetic potential of mitochondria. Its de-
crease causes the release of proapoptic factors from 
mitochondria into the cytosol. However calcium ions 
promoted the increase of transmembrane potential 
in some tissue samples [19]. The resistance of micro-
follicular cells to proapoptic signals is confirmed by our 
data obtained: decrease of the intensity of terminal 
stage of apoptosis — stimulated internucleosomic 
DNA fragmentation. 
It has been derermined the decrease of spontane-
ous apoptosis in extratumoral microfollicular thyroid 
tissue and its resistance to proapoptotic factors may 
be as a result of the tumor influence. It may be pro-
moted further tumor progression, as well as thyroid 
tissue stimulation by means of TSH. 
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